LIN vs XTNT · P/E 34, rev $33.99B vs rev $133.9M
Linde plc Ordinary Shares (LIN) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.
LIN currently screens at market cap $223.87B and trailing P/E 34.5. XTNT currently screens at market cap $91.0M.
Not investment advice. Open the LIN and XTNT stock pages for the full models.
Not investment advice.